The Notch1/cyclooxygenase-2/Snail/E-cadherin pathway is associated with hypoxia-induced hepatocellular carcinoma cell invasion and migration

Oncology Reports

Volumn 29, Issue 1, 2013, Pages 362-370

  Yu, Ling Xiang ^a   Zhou, Liang ^a   Li, Mo ^a   Li, Zhi Wei ^b   Wang, De Sheng ^a   Zhang, Shao Geng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Departments of Hepatobiliary Surgery   (China)

Author keywords

Cyclooxygenase 2; E cadherin; Hypoxia; Invasion; Migration; Notch1; Snail

Indexed keywords

CYCLOOXYGENASE 2; NOTCH1 RECEPTOR; PROSTAGLANDIN SYNTHASE; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HYPOXIA; LIVER CELL CARCINOMA; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANOXIA; APOPTOSIS; BLOTTING, WESTERN; CADHERINS; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CYCLOOXYGENASE 2; FLOW CYTOMETRY; HUMANS; LIVER NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, NOTCH1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 84872845181     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2103     Document Type: Article

References (52)

1. Yu MC, Yuan JM, Govindarajan S and Ross RK: Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 14: 703-709, 2000.
2. Tung-Ping Poon R, Fan ST and Wong J: Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232: 10-24, 2000.
3. Brahimi-Horn MC, Chiche J and Pouyssegur J: Hypoxia and cancer. J Mol Med 85: 1301-1307, 2007.
4. Graeber TG, Osmanian C, Jacks T, et al: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379: 88-91, 1996.
5. Cavallaro U and Christofori G: Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4: 118-132, 2004.
6. Choi YS, Shim YM, Kim SH, et al: Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer. Eur J Cardiothorac Surg 24: 441-449, 2003.
7. Bremnes RM, Veve R, Gabrielson E, et al: High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J Clin Oncol 20: 2417-2428, 2002.
8. Tsujii M and DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83: 493-501, 1995.
9. Liu D, Huang C, Kameyama K, et al: E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer. Ann Thorac Surg 71: 949-954, 2001.
10. Giroldi LA, Bringuier PP, de Weijert M, Jansen C, van Bokhoven A and Schalken JA: Role of E boxes in the repression of E-cadherin expression. Biochem Biophys Res Commun 241: 453-458, 1997.
11. Perl AK, Wilgenbus P, Dahl U, Semb H and Christofori G: A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392: 190-193, 1998.
12. Moody SE, Perez D, Pan TC, et al: The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8: 197-209, 2005.
13. Yan W, Fu Y, Tian D, et al: PI3 kinase/Akt signaling mediates epithelial-mesenchymal transition in hypoxic hepatocellular carcinoma cells. Biochem Biophys Res Commun 382: 631-636, 2009.
14. Cannito S, Novo E, Compagnone A, et al: Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis 29: 2267-2278, 2008.
15. Liu L, Ren ZG, Shen Y, et al: Influence of hepatic artery occlusion on tumor growth and metastatic potential in a human orthotopic hepatoma nude mouse model: relevance of epithelial-mesenchymal transition. Cancer Sci 101: 120-128, 2010.
16. Artavanis-Tsakonas S, Rand MD and Lake RJ: Notch signaling: cell fate control and signal integration in development. Science 284: 770-776, 1999.
17. Miele L and Osborne B: Arbiter of differentiation and death: Notch signaling meets apoptosis. J Cell Physiol 181: 393-409, 1999.
18. Gustafsson MV, Zheng X, Pereira T, et al: Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 9: 617-628, 2005.
19. Gao J, Song Z, Chen Y, et al: Deregulated expression of Notch receptors in human hepatocellular carcinoma. Dig Liver Dis 40: 114-121, 2008.
20. Zlobin A, Jang M and Miele L: Toward the rational design of cell fate modifiers: notch signaling as a target for novel biopharmaceuticals. Curr Pharm Biotechnol 1: 83-106, 2000.
21. Jang MS, Zlobin A, Kast WM and Miele L: Notch signaling as a target in multimodality cancer therapy. Curr Opin Mol Ther 2: 55-65, 2000.
22. Sahlgren C, Gustafsson MV, Jin S, Poellinger L and Lendahl U: Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA 105: 6392-6397, 2008.
23. Lim SO, Kim HS, Quan X, et al: Notch1 binds and induces degradation of Snail in hepatocellular carcinoma. BMC Biol 9: 83, 2011.
24. Llovet JM and Bruix J: Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48: 1312-1327, 2008.
25. Llovet JM, Burroughs A and Bruix J: Hepatocellular carcinoma. Lancet 362: 1907-1917, 2003.
26. Postovit LM, Adams MA, Lash GE, Heaton JP and Graham CH: Oxygen-mediated regulation of tumor cell invasiveness. Involvement of a nitric oxide signaling pathway. J Biol Chem 277: 35730-35737, 2002.
27. Rofstad EK: Microenvironment-induced cancer metastasis. Int J Radiat Biol 76: 589-605, 2000.
28. Lundgren K, Nordenskjold B and Landberg G: Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer. Br J Cancer 101: 1769-1781, 2009.
29. Wells A, Yates C and Shepard CR: E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metastasis 25: 621-628, 2008.
30. Osada T, Sakamoto M, Ino Y, et al: E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. Hepatology 24: 1460-1467, 1996.
31. Hotz B, Arndt M, Dullat S, Bhargava S, Buhr HJ and Hotz HG: Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res 13: 4769-4776, 2007.
32. Moreno-Bueno G, Cubillo E, Sarrio D, et al: Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res 66: 9543-9556, 2006.
33. Cano A, Perez-Moreno MA, Rodrigo I, et al: The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76-83, 2000.
34. Batlle E, Sancho E, Franci C, et al: The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89, 2000.
35. Yokoyama K, Kamata N, Hayashi E, et al: Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol 37: 65-71, 2001.
36. Jiao W, Miyazaki K and Kitajima Y: Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. Br J Cancer 86: 98-101, 2002.
37. Balint K, Xiao M, Pinnix CC, et al: Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression. J Clin Invest 115: 3166-3176, 2005.
38. Buchler P, Gazdhar A, Schubert M, et al: The Notch signaling pathway is related to neurovascular progression of pancreatic cancer. Ann Surg 242: 791-800, 2005.
39. Wang Z, Banerjee S, Li Y, Rahman KM, Zhang Y and Sarkar FH: Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res 66: 2778-2784, 2006.
40. Qi R, An H, Yu Y, et al: Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res 63: 8323-8329, 2003.
41. Dubinett SM, Sharma S, Huang M, Dohadwala M, Pold M and Mao JT: Cyclooxygenase-2 in lung cancer. Prog Exp Tumor Res 37: 138-162, 2003.
42. Dannenberg AJ and Subbaramaiah K: Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cell 4: 431-436, 2003.
43. Brown JR and DuBois RN: Cyclooxygenase as a target in lung cancer. Clin Cancer Res 10: S4266-S4269, 2004.
44. Dannenberg AJ and Zakim D: Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2. Semin Oncol 26: 499-504, 1999.
45. Huang M, Stolina M, Sharma S, et al: Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: upregulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res 58: 1208-1216, 1998.
46. Park K, Han S, Shin E, Kim HJ and Kim JY: Cox-2 expression on tissue microarray of breast cancer. Eur J Surg Oncol 32: 1093-1096, 2006.
47. Dohadwala M, Batra RK, Luo J, et al: Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion. J Biol Chem 277: 50828-50833, 2002.
48. Dohadwala M, Yang SC, Luo J, et al: Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Cancer Res 66: 5338-5345, 2006.
49. Yeh TS, Wu CW, Hsu KW, et al: The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2. Cancer Res 69: 5039-5048, 2009.
50. Noda M, Tatsumi Y, Tomizawa M, et al: Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines. J Gastroenterol 37: 896-904, 2002.
51. Lee DS and Moss SF: COX-2 inhibition and the prevention of gastric cancer. Digestion 74: 184-186, 2006.
52. Fujimura T, Ohta T, Oyama K, Miyashita T and Miwa K: Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience. World J Gastroenterol 12: 1336-1345, 2006.